首页|食管癌患者循环肿瘤细胞与临床特征和全身炎症标志物的关系及其预后价值

食管癌患者循环肿瘤细胞与临床特征和全身炎症标志物的关系及其预后价值

扫码查看
目的 构建一个列线图模型来评估食管癌(EC)患者根治性手术(RS)后的生存率,并通过限制性立方样条(RCS)来评估循环肿瘤细胞(CTC)、全身炎症标志物和预后之间的非线性关系.方法 测定RS后采集的500例EC患者血液中CTC计数,计算系统免疫炎症指数(SII)、中性粒细胞与淋巴细胞和血小板的比值(NLPR)、全身炎症聚集指数(AISI)和全身炎症反应指数(SIRI),分析临床数据与这些指标的相关性.评估CTC计数和全身炎症标志物对总生存期(OS)和无进展生存期(PFS)的预测价值.结果 CTC与临床特征(新辅助治疗、术前合并症、病理分级、脉管侵犯、神经侵犯和肿瘤大小)和炎症标志物(SII、NLPR、SIRI、AISI)存在较强的相关性.单因素和多因素Cox回归分析显示:新辅助治疗(P=0.031)、术前合并症(P=0.028)、治疗方式(P<0.001)、病理分级(P=0.006)、脉管侵犯(P=0.012)、神经侵犯(P=0.012)、SII(P<0.001)、NLPR(P=0.008)、AISI(P<0.001)、CTC(P<0.001)为独立的预后影响因素.T 分期(P=0.036)、N分期(P=0.002)和脉管侵犯(P<0.001)与PFS有相关性.RCS图显示CTC、SII、NLPR、SIRI和AISI与预后呈非线性关系.Kaplan-Meier生存曲线显示,CTC、SII、NLPR、SIRI和AISI值较低的患者OS和PFS较长(P<0.05).结论 CTC、SII、NLPR和AISI可能是EC患者行RS的临床预后的有力指标,结合这些因素的列线图和RCS有助于临床实践中患者预后的个体化判断.
Relationship and Prognostic Value of Circulating Tumor Cells with Clinical Characteristics and Systemic Inflammatory Markers in Esophageal Cancer Patients
Objective To develop a nomogram to estimate the probability of survival in patients with esophageal cancer(EC)after radical surgery(RS)and to evaluate the nonlinear relationship between circulating tumor cells(CTC),systemic inflammatory markers and prognosis by using combined restricted cubic splines(RCS).Methods CTC counts in blood samples from 500 patients with EC,which were collected after RS,were determined.The systemic immune-inflammation index(SII),neutrophil/(lymphocyte x platelet)ratio(NLPR),aggregate index of systemic inflammation(AISI)and systemic inflammation response index(SIRI)were calculated.The correlations between clinical data and these indices were analyzed.In addition,overall survival(OS)and progression-free survival(PFS)to assess the predictive value of CTC counts and systemic inflammatory markers were analyzed.Results CTC were strongly associated with clinical features(neoadjuvant therapy,preoperative comorbidities,pathological grade,vascular invasion,nerve invasion,tumor size)and inflammatory markers(SII,NLPR,SIRI,AISI).According to univariate and multivariate Cox regression analyses,the following factors were independent prognostic factors for survival:neoadjuvant therapy(P=0.031),preoperative comorbidities(P=0.028),treatment methods(P<0.001),pathological grade(P=0.006),vascular invasion(P=0.012),nerve invasion(P=0.012),the SII(P<0.001),the NLPR(P=0.008),the AISI(P<0.001)and the CTC(P<0.001).Four factors were significantly associated with PFS:neoadjuvant therapy,T stage(P=0.036),N stage(P=0.002)and vascular invasion(P<0.001).The RCS plot showed that the CTC,SII,NLPR,SIRI and AISI had a nonlinear relationship with prognosis.Furthermore,Kaplan-Meier survival curves revealed that patients with lower CTCs,SII,NLPR,SIRI and AISI values had significantly longer OS and PFS.Conclusion The CTC,SII,NLPR and AISI may be powerful indicators of clinical prognosis in EC patients undergoing RS.The nomograms and RCS incorporating these factors facilitate individualized determination of patient prognosis in clinical practice.

esophageal cancercirculating tumor cellinflammatory markeroverall survivalprogression-free survival

李延科、孟祥瑞、邢思远、宗上纲、王峰

展开 >

郑州大学第一附属医院肿瘤科,河南郑州 450000

河南省医学科学院,河南郑州 450000

食管癌 循环肿瘤细胞 炎症标志物 总生存期 无进展生存

河南省自然科学基金面上项目希思科-恒瑞肿瘤研究基金河南省医科院省属科研院所基本科研业务费项目

222300420557Y-HR2018-219JBKY202102

2024

河南医学研究
河南省医学科学院

河南医学研究

影响因子:0.979
ISSN:1004-437X
年,卷(期):2024.33(5)
  • 41